Log In
BCIQ
Print this Print this
 

TREM1 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Inotrem S.A.
DescriptionInhibitor of triggering receptor expressed on myeloid cells 1 (TREM1)
Molecular Target Triggering receptor expressed on myeloid cells 1 (TREM1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat excessive inflammation in severe sepsis patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today